Demethylating treatment suppresses natural killer cell cytolytic activity

被引:49
|
作者
Gao, Xiao-ning [1 ]
Lin, Ji [2 ]
Wang, Li-li [1 ]
Yu, Li [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Clin Div Internal Med, Dept Hematol, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Basic Med Inst, Res Lab Biochem, Beijing 100853, Peoples R China
基金
中国国家自然科学基金;
关键词
NK cell inhibitory receptors; DNA methylation; NK cells; Cytotoxicity; 5-Azacytidine; HUMAN NK CELLS; CLASS-I; DNA METHYLATION; EXPRESSION PATTERNS; GENE-EXPRESSION; ACTIVATION; CYTOTOXICITY; RECEPTORS; PERFORIN; LYSIS;
D O I
10.1016/j.molimm.2009.02.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NK cells as a component of the innate immune system provide a first line of defense against viral infections and malignancies. Killer immunoglobulin-like receptors (KIRs) are a polymorphic gene family expressed on NK cells. The crucial role of DNA methylation in determining the variegated expression pattern of KIRs has recently been reported. In this study the direct effect of DNA demethylating treatment on human NK cell cytotoxicity was analyzed. In a human NK cell line NK-92MI, inhibitory KIR genes exhibited characteristic epigenetic repression, whose promoter regions are densely methylated. Treatment of NK-92MI cells with methyltransferase inhibitor 5-azacytidine significantly increased the expression levels of inhibitory KIRs and strongly suppressed their cytolytic activity against human K562 leukemic cells. Cytolytic activity of human polyclonal NK cells was also suppressed upon 5-azacytidine-treatment. The suppression of NK cell cytotoxicity was associated with 5-azacytidine-induced overexpression of inhibitory KIRs and impaired granzyme B and perforin release by these cells. The results demonstrate for the first time that demethylating treatment can suppress NK cell cytolytic activity. The aberrant methylation patterns of KIR genes during NK cell differentiation and maturation may have importance for its abnormal function. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2064 / 2070
页数:7
相关论文
共 50 条
  • [31] ASCORBIC-ACID SUPPRESSES NATURAL-KILLER-CELL ACTIVITY IN BUFO-MARINUS
    GHONEUM, M
    SADEK, IA
    GILL, G
    COOPER, EL
    DISEASES OF AQUATIC ORGANISMS, 1990, 9 (01) : 1 - 4
  • [32] Evaluation of natural killer cell activity
    Josephine H. Cox
    Mark deSouza
    Molecular Biotechnology, 2000, 15 : 147 - 154
  • [33] Evaluation of natural killer cell activity
    Cox, JH
    deSouza, M
    MOLECULAR BIOTECHNOLOGY, 2000, 15 (02) : 147 - 154
  • [34] Regulation of natural killer cell activity
    Kirwan, Sheryl E.
    Burshtyn, Deborah N.
    CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (01) : 46 - 54
  • [35] PURIFICATION AND CHARACTERIZATION OF CYTOLYTIC AND NONCYTOLYTIC HUMAN NATURAL-KILLER-CELL SUBSETS
    LEBOW, LT
    BONAVIDA, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) : 6063 - 6067
  • [36] Uncoupling of Natural Killer cell functional maturation and cytolytic function in NOD mice
    Bourel, Capucine
    Mullins-Dansereau, Victor
    Al Khaldi, Maher
    Chabot-Roy, Genevieve
    Lombard-Vadnais, Felix
    Lesage, Sylvie
    IMMUNOLOGY AND CELL BIOLOGY, 2023, 101 (09): : 867 - 874
  • [37] Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection
    Scott, MJ
    Hoth, JJ
    Turina, M
    Woods, DR
    Cheadle, WG
    CYTOKINE, 2006, 33 (02) : 79 - 86
  • [38] Effects of Ziram on Humman Natural Killer Cell MAP Kinases and Cytolytic Proteins
    Taylor, Thyneice Rochelle
    Whalen, Margaret M.
    FASEB JOURNAL, 2010, 24
  • [39] Quantitative spatio-temporal analysis of cytolytic and non-cytolytic natural killer cell immune synapse
    Vyas, Y
    Maniar, H
    Dupont, B
    TISSUE ANTIGENS, 2002, 59 : 4 - 4
  • [40] Silk peptide treatment potentiates natural killer cell activity in vitro and induces natural killer cell maturation and activation in mouse splenocytes
    Jang, Sun-Hee
    Oh, Mi-Sun
    Baek, Hyang-Im
    Ha, Ki-Chan
    Lee, Jeong-Yong
    Jang, Yong-Suk
    PHARMACEUTICAL BIOLOGY, 2019, 57 (01) : 369 - 379